Identification
A:
Thin-Layer Chromatographic Identification Test 201
Test solution
Transfer a quantity of finely powdered Tablets, equivalent to about 5 mg of letrozole, to a centrifuge tube, add 2.5 mL of methanol, shake thoroughly, sonicate for 10 minutes, and centrifuge.
Application volume:
5 µL.
Developing solvent system:
a mixture of ethyl acetate and methanol (9:1).
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution 711
Medium:
0.1 N hydrochloric acid; 500 mL.
Apparatus 2:
75 rpm.
Time:
30 minutes.
Determine the amount of C17H11N5 dissolved by employing the following method.
Mobile phase
and Chromatographic systemPrepare as directed in the Assay.
Procedure
Inject a volume (about 200 µL) of a filtered portion of the solution under test into the chromatograph, record the chromatogram, and measure the responses for the major peaks. Calculate the quantity, in mg, of C
17H
11N
5 dissolved in comparison with a Standard solution having a known concentration of
USP Letrozole RS in the same
Medium and similarly chromatographed.
Tolerances
Not less than 80% (Q) of the labeled amount of C17H11N5 is dissolved in 30 minutes.
Related compounds
Solution A, Solution B, Mobile phase, and Diluent
Prepare as directed in the
Assay under
Letrozole.
System suitability solution, Reference solution, and Chromatographic system
Proceed as directed in the test for
Related compounds under
Letrozole, except to use an injection volume of 50 µL.
Test solution
Place a number of Tablets, equivalent to about 25 mg of letrozole, in a 250-mL volumetric flask. Add 150 mL of Diluent, shake for 15 minutes, dilute with Diluent to volume, and mix. Centrifuge a portion of this solution, and dilute an accurately measured volume of it with Diluent to obtain a solution containing about 10 µg of letrozole per mL.
Procedure
Proceed as directed in the test for
Related compounds under
Letrozole, except to use an injection volume of 50 µL. Calculate the percentage of each letrozole related compound in the Tablets, disregarding any values obtained that are less than 0.05%: not more than 0.3% of letrozole related compound A is found; not more than 0.2% of 4,4
¢,4
¢¢-methylidenetrisbenzonitrile is found; not more than 0.1% of any other impurity is found; and not more than 0.3% of all other impurities is found.
Assay
Diluent
Prepare a filtered and degassed mixture of water and acetonitrile (7:3).
Mobile phase
Prepare a filtered and degassed mixture of water and acetonitrile (13:12). Make adjustments if necessary (see
System Suitability under
Chromatography 621).
System suitability solution
Prepare as directed in the
Related compounds test under
Letrozole.
Standard preparation
Prepare as directed in the
Assay under
Letrozole.
Assay preparation
Place a number of Tablets, equivalent to about 50 mg of letrozole, in a 250-mL volumetric flask. Add about 20 mL of water, and shake for 5 minutes to dissolve the Tablets. Add 75 mL of acetonitrile, shake for 30 minutes, and dilute with water to volume. Centrifuge a portion of the solution. Dilute an accurately measured volume of this solution with Diluent, to obtain a solution containing about 10 µg of letrozole per mL.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 230-nm detector and a 4.6-mm × 12.5-cm column that contains 5-µm packing L1. The flow rate is about 1.0 mL per minute. Chromatograph the
System suitability solution, and record the peak responses as directed for
Procedure: the relative retention times are about 0.68 for letrozole related compound A and 1.0 for letrozole; and the resolution,
R, between letrozole related compound A and letrozole is not less than 1.5. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the tailing factor is between 0.8 and 1.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 20 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in mg, of letrozole (C
17H
11N
5) in the portion of Tablets taken by the formula:
5000C(rU / rS),
in which
C is the concentration, in mg per mL, of
USP Letrozole RS in the
Standard preparation; and
rU and
rS are the peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.